Treatment of prostatic bleeding: suppression of angiogenesis by androgen deprivation.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 7684792.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Bleeding of prostatic origin is usually caused by the friable hypervascularity of the aging prostate. Suppression of angiogenesis can be achieved through any hormonal manipulation that causes androgen deprivation. We present 4 cases of severe recurrent hematuria treated successfully by this approach.
Medical subject headings
- Diethylstilbestrol
- Estrogens, Conjugated (USP)
- Flutamide
- Hematuria
- Neovascularization, Pathologic
- Prostate